Asset Manager

Updated:

Life Sciences Greenhouse of Central Pennsylvania

The Life Sciences Greenhouse of Central Pennsylvania emerged from a 2002 state initiative that carved Pennsylvania into three investment zones, each with...

Life Sciences Greenhouse of Central Pennsylvania

The Life Sciences Greenhouse of Central Pennsylvania emerged from a 2002 state initiative that carved Pennsylvania into three investment zones, each with a dedicated commercialization engine. Thomas S. Grogan leads the central Pennsylvania operation, succeeding founding CEO Melvin L. Billingsley. The Pennsylvania Department of Community and Economic Development provides oversight and funding, making the greenhouse a hybrid: part economic development vehicle, part venture investor. The firm deploys capital across biotechnology, medical devices, diagnostics, and healthcare IT, targeting pre-seed through Series A companies spun out of Penn State, Penn State Hershey, and other regional research institutions. It co-invests frequently with Ben Franklin Technology Partners, another state-backed network. The greenhouse takes equity positions and provides commercialization grants, though specific portfolio holdings remain closely held. Its geographic mandate spans 31 counties, from the Susquehanna Valley through the Northern Tier. The management team includes Senior Vice President Kevin Harter, a co-founder, and Vice President of Venture Operations Stephen Carpenter. The greenhouse maintains dual offices on Front Street and Market Street in Harrisburg. It participates in Life Sciences Pennsylvania, the regional trade association, and the Association of University Technology Managers, reflecting its focus on technology transfer from lab to market. The greenhouse's architecture as a state-funded, regionally bounded investor creates a structural differentiator: it must balance fiduciary returns with legislative mandates for job creation and economic development in a specific geography. This tension shapes every investment decision — a discipline rare among pure-play venture firms but common across Pennsylvania's three-greenhouse system.

General information

Firm type

Generalist

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Harrisburg

Corporate office

225 Market Street, Suite 500, Harrisburg, PA 17101, United States

Additional offices

3211 N Front St Ste 201, Harrisburg, PA 17110

Principals

Thomas S. Grogan

President and CEO

Melvin L. Billingsley

Former President and CEO

Kevin Harter

Senior Vice President and Co-founder

Stephen Carpenter

Vice President of Venture Operations

Sector focus

Life SciencesDigital HealthHealthcare ServicesAgriTech & FoodTech

Frequently asked questions

Who runs investment decisions at Life Sciences Greenhouse of Central Pennsylvania?

Thomas S. Grogan serves as President and CEO, leading investment strategy and operations. Kevin Harter, Senior Vice President and co-founder, and Stephen Carpenter, Vice President of Venture Operations, round out the senior team. Melvin L. Billingsley previously held the CEO role before Grogan.

How is Life Sciences Greenhouse of Central Pennsylvania funded?

The Pennsylvania Department of Community and Economic Development provides state funding and oversight. The greenhouse also pursues institutional partnerships and co-investment relationships. This public backing distinguishes it from privately capitalized venture firms.

What is the greenhouse's relationship to Ben Franklin Technology Partners?

Ben Franklin Technology Partners is a frequent co-investment partner. Both entities operate with Pennsylvania state backing but maintain separate organizational structures and geographic or functional mandates. Their co-investments provide portfolio companies with layered state support.

What geographic areas does the greenhouse cover?

The firm covers a 31-county region in central Pennsylvania, anchored by research institutions including Penn State and Penn State Hershey. This region spans from the Susquehanna Valley through the Northern Tier, making the greenhouse the primary life sciences commercialization vehicle for the area.

What types of companies does the greenhouse back?

The firm invests in early-stage life sciences companies — pre-seed through Series A — in biotechnology, medical devices, diagnostics, and healthcare IT. It provides both equity investments and commercialization grants, typically targeting university spinouts and startups within its 31-county mandate.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo